News
The European Medicines Agency (EMA) initiates a review of sodium oxybate-containing medications for alcohol dependency, ...
The European agency has started a review of sodium oxybate to assess its use to treat alcohol withdrawal syndrome and support ...
9h
GlobalData on MSNMadrigal poised to enter European MASH market after CHMP endorsementRevenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.
The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...
In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...
The drug, sold as Rezdiffra, was first approved in the United States in March last year. The disease known as non-alcoholic ...
The European Union's medicines regulator on Friday granted a conditional authorisation for Madrigal Pharmaceuticals' drug for ...
The European Medicines Agency’s human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines at its June meeting.
GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...
Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...
A comprehensive analysis conducted by public health experts at Novartis Romania reveals that Romanian patients may wait, on ...
Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results